28th March 2017
Further to previous announcements, Cloudtag Inc. (or “the Company”) announces that, with effect from 28 March 2017, its shares will be delisted from the Alternative Investment Market of the London Stock Exchange (“AIM”). On 28 February 2017, Cloudtag’s Nomad resigned with immediate effect and, in the short timescale dictated by AIM’s Rules for Companies, no replacement has been appointed. Accordingly, Cloudtag will no longer be a Company listed on AIM, and consequently its shares will no longer be publicly traded.
The Board of Cloudtag recognises that its AIM listing provided a platform for investors to trade in our shares which will no longer be available. We wish to reassure all our shareholders that our status as a private company will not diminish our focus on protecting their interests. In due course, we will seek a return to a trading platform. Throughout the past year we have raised funds as and when required and will continue to follow this approach.
The Company’s primary focus in the immediate term is the launch of its first product. We are close to this significant milestone, and have a factory-produced working product which we have been using to give live demonstrations to potential customers and investors. The Company has identified a number of opportunities in the B2B market. We plan to exhibit at the UK eHealth Week event on 3-4 May 2017, which focuses on people and organisations that use the power of IT to transform healthcare, in association with NHS England and NHS Digital.
| Cloudtag Inc. Amit Ben-Haim | +1 345 949 45 44 contact@cloudtag.com |
| UK Investor Relations. | +44 (0) 20 7052 8469 investors@cloudtag.com |